Pharmaceutical Companies' Profits Soar with Sales Growth and Efficient Management.
The study looked at how Sales Growth, Current Ratio, and Net Profit Margin affect Return On Asset in pharmaceutical companies. They analyzed data from 6 companies listed on the stock exchange from 2015 to 2020. The results showed that Sales Growth had no significant impact on Return On Asset, while Current Ratio and Net Profit Margin had a positive and significant effect on it.